PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
17-Jul-2023 PAION AG: HANA PHARM RECEIVES MARKET APPROVAL FOR BYFAVO IN GENERAL ANESTHESIA IN THE PHILIPPINES PAION AG
17-Jul-2023 Affluent Medical strengthens management team to advance its development Affluent Medical SA
17-Jul-2023 SYNLAB AG: SYNLAB plays key role in the largest ever multinational study on cholesterol SYNLAB AG
17-Jul-2023 Straumann Group appoints Yang Xu as Chief Financial Officer Straumann Holding AG
14-Jul-2023 Drägerwerk AG & Co. KGaA: Preliminary figures H1 2023: Net sales and earnings significantly above prior year – full-year guidance reaffirmed Drägerwerk AG & Co. KGaA
14-Jul-2023 Angelini Pharma launches LIFE-GREENAPI as part of its green transition strategy, supported with a €1.5M grant from the European Commission Angelini Pharma
14-Jul-2023 TME PHARMA PROVIDES POSITIVE DATA UPDATE ON BEST RESPONSE TO THERAPY WITH FIRST COMPLETE RESPONSE IN GLORIA TRIAL IN GLIOBLASTOMA, BRINGING 50% OF PATIENTS IN EXPANSION ARM TO COMPLETE OR NEAR-COMPLETE RESPONSE TME PHARMA
14-Jul-2023 SiSaf Appoints Nikos Tzagkarakis in the New Role of Chief A.I. Officer SiSaf
14-Jul-2023 HUTCHMED Announces Changes to Board of Directors and Technical Committee HUTCHMED
14-Jul-2023 Vicore announces the appointment of Ahmed Mousa as CEO Vicore
14-Jul-2023 CureVac Announces Update to the Management Team CureVac
14-Jul-2023 Original-Research: HAEMATO AG (von GBC AG) HAEMATO AG
13-Jul-2023 Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial Kuros Biosciences AG
13-Jul-2023 Landmark study demonstrates economic edge of precision medicine that we can’t afford to ignore Diaceutics Plc
13-Jul-2023 CureVac Strengthens Ongoing Patent Litigations Bringing Additional Cases Under New Intellectual Property Rights CureVac
13-Jul-2023 TRYP THERAPEUTICS RECEIVES CONFIRMATION FROM FDA TO PROCEED WITH PHASE 2A CLINICAL TRIAL IN PATIENTS WITH IBS AT MASSACHUSETTS GENERAL HOSPITAL Tryp Therapeutics Inc.
13-Jul-2023 Cantourage Group SE welcomes draft bill of the Federal Ministry of Health on the new Cannabis Act and an amendment to the Medical Cannabis Act Cantourage Group SE
13-Jul-2023 Peer-reviewed publication by Marinomed Biotech AG and Friedrich-Alexander-University Erlangen-Nürnberg reconfirms broad virus-blocking effectiveness of iota-carrageenan Marinomed Biotech AG
13-Jul-2023 Heidelberg Pharma Reports on First Half-Year 2023 and the Course of Business Heidelberg Pharma AG
13-Jul-2023 PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023 PolyPeptide Group